Stocks News

LAST PRICE
57.9800
TODAY'S CHANGE (%)
Trending Up2.1400 (3.8324%)

Bid / Lots
57.1000/ 4
Ask / Lots
59.7700/ 2
Open / Previous Close
56.3100 / 55.8400
Day Range
Low 56.1004
High 58.7400
52 Week Range
Low 30.6800
High 110.2500
Volume
1,719,834
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 8, 2024
- RBC Starts Cytokinetics With Outperform Rating, $80 Price Target, from 8:51AM ET on Friday Nov 08, 2024 by MT Newswires
  8:51AM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: CYTK
  08:51 AM EST, 11/08/2024 (MT Newswires) -- Cytokinetics (CYTK) has an average rating of outperform and price targets ranging from $60 to $120, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research f...
- DJ Cytokinetics Initiated at Outperform by RBC Capital, from 6:56AM ET on Friday Nov 08, 2024 by Dow Jones
  6:56AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: CYTK
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/CYTK/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 08, 2024 06:56 ET (11:56 GMT)
Nov 7, 2024
- DJ Cytokinetics Price Target Maintained With a $120.00/Share by HC Wainwright & Co., from 3:31PM ET on Thursday Nov 07, 2024 by Dow Jones
  3:31PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: CYTK
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/CYTK/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 15:31 ET (20:31 GMT)
- Cytokinetics Q3 Loss Widens, Revenue Rises, from 5:59AM ET on Thursday Nov 07, 2024 by MT Newswires
  5:59AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: CYTK
  05:59 AM EST, 11/07/2024 (MT Newswires) -- Cytokinetics (CYTK) reported late Wednesday Q3 net loss of $1.36 per share, wider than the $1.35 loss per share a year earlier. Analysts polled by Capital IQ expected $1.27 loss per share. Revenue for the q...
Nov 6, 2024
- -- Earnings Flash (CYTK) CYTOKINETICS INCORPORATED Posts Q3 Revenue $500,000, from 4:01PM ET on Wednesday Nov 06, 2024 by MT Newswires
  4:01PM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: CYTK
  04:01 PM EST, 11/06/2024 (MT Newswires) -- ...

Nov 8, 2024
- Lost Money on Viking Therapeutics, Inc. (VKTX)? Contact Levi & Korsinsky Regarding an Ongoing Investigation, from 7:26AM ET on Friday Nov 08, 2024 by Dow Jones
  7:26AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: VKTX
Nov 7, 2024
- Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Thursday Nov 07, 2024 by PR Newswire
  4:05PM ET on Thursday Nov 07, 2024 by PR Newswire
  Companies Mentioned: RNA
- Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: RNA
- *DJ Avidity Biosciences 3Q Loss/Shr 65c >RNA, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: RNA
Nov 6, 2024
- ATTENTION Viking Therapeutics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights, from 1:01PM ET on Wednesday Nov 06, 2024 by Dow Jones
  1:01PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: VKTX
- Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: MDGL
- Madrigal Pharmaceuticals Insider Sold Shares Worth $1,504,703, According to a Recent SEC Filing, from 3:28AM ET on Wednesday Nov 06, 2024 by MT Newswires
  3:28AM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: MDGL
Nov 5, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX, from 12:01PM ET on Tuesday Nov 05, 2024 by Dow Jones
  12:01PM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: VKTX
- DJ Madrigal Pharmaceuticals Is Maintained at Neutral by B. Riley Securities, from 11:22AM ET on Tuesday Nov 05, 2024 by Dow Jones
  11:22AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: MDGL
- DJ Viking Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 9:27AM ET on Tuesday Nov 05, 2024 by Dow Jones
  9:27AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: VKTX

Cytokinetics Inc
NASDAQ:CYTKUnited States

Search Criteria

Nov 8, 2024

RBC Starts Cytokinetics With Outperform Rating, $80 Price Target, from 8:51AM ET on Friday Nov 08, 2024 by MT Newswires

DJ Cytokinetics Initiated at Outperform by RBC Capital, from 6:56AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 7, 2024

DJ Cytokinetics Price Target Maintained With a $120.00/Share by HC Wainwright & Co., from 3:31PM ET on Thursday Nov 07, 2024 by Dow Jones

Cytokinetics Q3 Loss Widens, Revenue Rises, from 5:59AM ET on Thursday Nov 07, 2024 by MT Newswires

Nov 6, 2024

-- Earnings Flash (CYTK) CYTOKINETICS INCORPORATED Posts Q3 Revenue $500,000, from 4:01PM ET on Wednesday Nov 06, 2024 by MT Newswires

Peers Headlines

Nov 8, 2024

Lost Money on Viking Therapeutics, Inc. (VKTX)? Contact Levi & Korsinsky Regarding an Ongoing Investigation, from 7:26AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 7, 2024

Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Thursday Nov 07, 2024 by PR Newswire

Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones

*DJ Avidity Biosciences 3Q Loss/Shr 65c >RNA, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 6, 2024

ATTENTION Viking Therapeutics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights, from 1:01PM ET on Wednesday Nov 06, 2024 by Dow Jones

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones

Madrigal Pharmaceuticals Insider Sold Shares Worth $1,504,703, According to a Recent SEC Filing, from 3:28AM ET on Wednesday Nov 06, 2024 by MT Newswires

Nov 5, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX, from 12:01PM ET on Tuesday Nov 05, 2024 by Dow Jones

DJ Madrigal Pharmaceuticals Is Maintained at Neutral by B. Riley Securities, from 11:22AM ET on Tuesday Nov 05, 2024 by Dow Jones

DJ Viking Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 9:27AM ET on Tuesday Nov 05, 2024 by Dow Jones